Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Ensign Group is a leading US-based operator of skilled nursing, rehabilitation, and senior living facilities with over 340 sites across 17 states as of Q2 2025. It is not a drug developer and does not conduct clinical research or market therapeutic products, but is recognized for its decentralized, facility-level management model and a disciplined track record of successful acquisitions and quality-of-care improvement. The company operates on a commercial scale, posting estimated revenues of $4–5 billion for fiscal year 2024–2025[1][2][3][5][10].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Ensign Group.